CV

Healthcare Media & Clinician Networks · Retailer & Marketplace

CVS Health

Integrated US pharmacy, insurance, care delivery and retail media company.

Available information varies by company and source.

Profile record updated:

Company facts

Official name
CVS Health Corporation
Entity type
COMPANY
Headquarters
United States
Company size
>5,000
Market cluster / sector
Healthcare Media & Clinician Networks
Market role
Retailer & Marketplace
Ticker
CVS
Official website
cvshealth.com

What CVS Health does

CVS Health operates an integrated healthcare model that connects insurance coverage, pharmacy benefit administration, prescription dispensing, clinical care delivery and consumer retail. Aetna contracts with employers, government programmes and members for health coverage. CVS Caremark administers pharmacy benefits for plan sponsors, while CVS Pharmacy, CVS Specialty and mail-order services fulfil prescriptions. Oak Street Health and Signify Health support payer-funded value-based care and in-home evaluations. Cordavis commercialises biosimilars with pharmaceutical manufacturers. CVS Media Exchange monetises CVS-owned shopper touchpoints and first-party loyalty audiences through advertising inventory and campaign services.

Category differentiation

CVS Health is the parent healthcare corporation, not solely the CVS Pharmacy retail chain or the CVS Media Exchange retail media unit. It is not a pure health insurer, pharmacy benefit manager or retailer because it operates all of these businesses alongside care-delivery assets.

Strategic context

AI-supported assessment from the existing company research; distinguish interpretation from sourced facts.

CVS Health Corporation is a publicly listed US health solutions company integrating retail pharmacy, pharmacy benefit management, health insurance, specialty pharmacy, primary care, in-home health assessments and value-based care. Its principal businesses include Aetna, CVS Caremark, CVS Pharmacy, CVS Specialty, MinuteClinic, Oak Street Health, Signify Health and Cordavis. CVS Media Exchange operates a separate retail media network serving brands and agencies using CVS Pharmacy and ExtraCare shopper audiences. The company earns insurance premiums; pharmacy-benefit administration and pharmacy-network economics; prescription, specialty-drug and retail merchandise sales; payer reimbursements and value-based-care payments; pharmaceutical commercialisation revenue; and advertising revenue. Customers include employers, insurers, government health programmes, plan sponsors, pharmaceutical manufacturers, healthcare providers, patients, consumers, consumer-product brands and advertising agencies.

Company news briefing

Briefing updated:

CVS Health delivered strong Q2 2026 results with 7.3% consolidated revenue growth, driven by operational simplification, AI enablement, and an expanded focus on GLP-1 therapies and integrated healthcare services. The company participates in Simile's $200M Series B financing via CVS Health Ventures, leveraging behavioural foundation models and synthetic populations for enterprise simulations. Additionally, CVS Health Media Exchange partnered with Circana to advance cross-retailer measurement, while retail footprint expansion includes onboarding GLP-1 friendly product lines such as Kate Farms shakes.

Business model & monetisation

CVS Health monetises through health-insurance premiums and member or sponsor contracts; pharmacy benefit management fees, network economics, formulary management and manufacturer-related drug economics; retail and specialty prescription dispensing; sales of health, wellness and general merchandise; payer reimbursement and value-based-care contracts; pharmaceutical manufacturer commercialisation and co-production arrangements for biosimilars; and retail media. CVS Media Exchange uses CPC sponsored-product auctions, CPM sponsored-brand placements, managed campaign fees, and offsite, video, social, audio and in-store advertising packages.

Health insurance premiums and plan contracts
Insurance premium revenue from commercial, Medicare, Medicaid and individual coverage.
Pharmacy benefit management and prescription fulfilment
Plan administration, formulary, pharmacy network, specialty and mail-order pharmacy economics.
Retail pharmacy and consumer wellness sales
Prescription dispensing and retail margin on health, wellness and general merchandise.
Care delivery and value-based care
Payer reimbursement, contracted clinical services and outcome-linked value-based payments.
Retail media and biosimilar commercialisation
CPC, CPM and managed advertising fees; manufacturer commercialisation arrangements.

Products & capabilities

No products with linked sources are available in this view.

Polaris7 Intelligence

Unlock Full Intelligence Profile for CVS Health

Get unlimited access to corporate ownership, historical M&A transactions, verified tech stack telemetry, and live market signals in the interactive Knowledge Graph.

Verified Ownership & Corporate Hierarchy

Complete corporate hierarchy traversal, shareholder cap table history, and parent holding links sourced from regulatory filings.

360° Tech Stack & Vendor Telemetry

Technical header bidding configurations, sellers.json registry nodes, CMP disclosures, and direct programmatic supply chains.

Live Market Signals & Executive Briefings

Continuous 24/7 monitoring of material M&A deals, executive shifts, product rollouts, and hiring trends across peer entities.

Verified primary sourcesContinuous signal monitoring1-click Google/LinkedIn
Unlock Full Intelligence Profile

Competitors & alternatives

Track competitor shifts

Receive automated telemetry on strategic moves, acquisitions, and market share shifts across CVS Health's competitive landscape.

Monitor company

Recent recorded signals

Dates refer to the source publication. Older entries are historical context, not evidence of a new event.

  • CVS Health Furnishes Q3 2026 Earnings Release via Form 8-K

    2 SourcesSEC API·SEC API

    financials · Recorded impact score: 4.8/5

    CVS Health Corporation reported consolidated revenues of $108.40 billion for Q3 2026, representing a 5.4% year-over-year increase driven by volume and pricing expansion across Health Services and Health Care Benefits. Operating income rebounded sharply to $3.57 billion compared to an operating loss of $3.21 billion in Q3 2025, primarily due to the absence of a prior-year $5.73 billion goodwill impairment in Health Care Delivery and improved medical loss ratio performance in Health Care Benefits (MBR decreased 150 bps to 91.3%). Net income attributable to CVS Health reached $2.17 billion ($1.68 diluted EPS), supported by strong nine-month operating cash flow of $15.32 billion. Concurrently, CVS announced a definitive plan to separate into two independent publicly traded entities by H1 2028: a healthcare solutions entity (encompassing Aetna, Caremark, CVS Specialty, Oak Street Health, and Signify Health) and a standalone retail pharmacy and community care business (CVS Pharmacy).

    • Q3 2026 consolidated revenue rose 5.4% year-over-year to $108.40B, and operating income reached $3.57B against an operating loss of $3.21B in Q3 2025.
    • Health Care Benefits MBR improved by 150 bps to 91.3% in Q3 2026, with segment adjusted operating income surging 190.4% to $912M.
  • 8-K Financial Filing Analysis for CVS Health (2026-11-04)

    sec.gov

    financials · Recorded impact score: 4.8/5

    On November 4, 2026, CVS Health Corporation furnished a Current Report on Form 8-K announcing its plan to execute a corporate breakup into two independent, publicly traded companies. Disclosed under Item 7.01 (Regulation FD Disclosure), the separation is intended to be structured as a tax-free spin-off for U.S. federal income tax purposes to the company and its shareholders. The transaction represents a structural pivot from CVS Health's integrated healthcare conglomerate model, designed to unlock shareholder value by creating distinct, standalone operating entities.

    • CVS Health announced its intention on November 4, 2026, to separate into two independent, publicly traded companies.
    • The transaction is intended to be structured as tax-free for U.S. federal income tax purposes for both the company and its shareholders.
  • Goldman recommends defensive stocks amid AI bull concerns

    cnbc.com

    Financials · Recorded impact score: 2/5

    Goldman Sachs advises investors concerned about a potential slowdown in the AI trade to consider defensive stocks in health care and consumer staples. The bank notes that AI capital spending currently contributes about half of S&P 500 earnings growth, but expects this to diminish as spending growth slows. Rising energy prices and interest rates are clouding the economic outlook, with higher financing costs raising doubts about the durability of the AI infrastructure buildout. Goldman's screen highlights companies with high free cash flow yields and recent underperformance, such as Tyson Foods (11% FCF yield, down 17% over six months) and CVS Health (9% FCF yield, down 15% in three months). Despite these defensive recommendations, Goldman's base case still expects continued earnings growth, with a potential catch-up trade in consumer-facing stocks fueled by weaker energy prices and falling interest rates anticipated in 2027.

    • Goldman Sachs recommends defensive stocks in health care and consumer staples amid AI trade concerns.
    • AI capital spending contributes about half of S&P 500 earnings growth, but Goldman expects this to diminish.
  • Pixability Appoints Norm de Greve, Former General Motors CMO and Chairman of the MMA, to its Advisory Board

    Leadership & People · Recorded impact score: 3/5

    Pixability, an AI-driven technology company helping brands maximize YouTube advertising, creator and organic strategies, announced on September 9, 2026 that Norm de Greve joined its Advisory Board. De Greve is Chairman of the MMA and former Chief Growth Officer and Global Chief Marketing Officer of General Motors, and previously CMO of CVS Health. Pixability CEO David George said de Greve's brand-side experience will help customers maximize YouTube investments as AI transforms marketing.

    • On September 9, 2026, Pixability announced the appointment of Norm de Greve to its Advisory Board.
    • De Greve currently serves as Chairman of the MMA and most recently was Chief Growth Officer and Global Chief Marketing Officer at General Motors.

Explore company relationships

Questions about CVS Health

What is CVS Health?

CVS Health is a US public healthcare corporation operating health insurance, pharmacy benefit management, retail and specialty pharmacy, clinical care and retail media businesses.

Who uses CVS Health?

Its customers include employers, insurers, government programmes, plan sponsors, pharmaceutical manufacturers, providers, advertisers, patients and retail consumers.

How does CVS Health make money?

It earns insurance premiums, PBM and pharmacy-service revenue, prescription and retail sales, payer reimbursements, value-based-care payments, manufacturer revenue and retail-media advertising fees.

Sources & coverage

This profile uses public, official and technically observable information. Missing information does not prove that a product or relationship does not exist. The list below does not imply that every profile statement has been verified.

4 publicly documented primary sources and citations linked across the market graph.

Continue your research on CVS Health

Open additional company details, personal Watchlists and your Strategic Intelligence Agent in Polaris7. It monitors your market daily and delivers tailored briefings with clear strategic context whenever relevant news occurs.

Daily intelligent monitoring · Verified primary sources.